Immunomodulation by hepatitis C virus-derived proteins: Targeting human dendritic cells by multiple mechanisms

International Immunology

Volumn 22, Issue 6, 2010, Pages 491-502

  Krishnadas, Deepa K ^a   Ahn, Justin S ^a   Han, Jiang ^a   Kumar, Rakesh ^a   Agrawal, Babita ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

DCs; HCV; Modulation; TLRs

Indexed keywords

CORE PROTEIN; FAS LIGAND; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 4; NONSTRUCTURAL PROTEIN 5; POLYPROTEIN; VIRUS PROTEIN; CYTOKINE; TOLL LIKE RECEPTOR;

ALLOIMMUNITY; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL FUNCTION; CELL STRAIN HEK293; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DOWN REGULATION; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOMODULATION; MALE; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION; ANTIGEN PRESENTATION; BIOSYNTHESIS; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; GENETICS; HEPACIVIRUS; IMMUNE EVASION; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY; SECRETION (PROCESS); T LYMPHOCYTE; VIROLOGY; VIRUS REPLICATION;

ANTIGEN PRESENTATION; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CYTOKINES; DENDRITIC CELLS; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; IMMUNE EVASION; IMMUNOMODULATION; T-LYMPHOCYTES; TOLL-LIKE RECEPTORS; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 77954025058     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxq033     Document Type: Article

References (63)

1. Santantonio, T., Fasano, M., Sinisi, E. et al. 2005. Efficacy of a 24-week course of PEG-interferon alpha-2b monotherapy in patients with acute hepatitis C after failure of spontaneous clearance. J. Hepatol. 42:329.
2. Koziel, M. J. 1996. Immunology of viral hepatitis. Am. J. Med. 100:98.
3. Chang, K. M., Rehermann, B. and Chisari, F. V. 1997. Immunopathology of hepatitis C. Springer Semin. Immunopathol. 19:57.
4. Chien, D. Y., Choo, Q. L., Ralston, R. et al. 1993. Persistence of HCV despite antibodies to both putative envelope glycoproteins. Lancet 342:933.
5. Chisari, F. V. 2005. Unscrambling hepatitis C virus-host interactions. Nature 436:930.
6. Smyk-Pearson, S., Tester, I. A., Lezotte, D., Sasaki, A. W., Lewinsohn, D. M. and Rosen, H. R. 2006. Differential antigenic hierarchy associated with spontaneous recovery from hepatitis C virus infection: implications for vaccine design. J. Infect. Dis. 194:454.
7. Urbani, S., Amadei, B., Fisicaro, P. et al. 2006. Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses. Hepatology 44:126.
8. Hiroishi, K., Kita, H., Kojima, M. et al. 1997. Cytotoxic T lymphocyte response and viral load in hepatitis C virus infection. Hepatology 25:705.
9. Wong, D. K., Dudley, D. D., Afdhal, N. H. et al. 1998. Liver-derived CTL in hepatitis C virus infection: breadth and specificity of responses in a cohort of persons with chronic infection. J. Immunol. 160:1479.
10. Rehermann, B., Chang, K. M., McHutchinson, J. et al. 1996. Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients. J. Virol. 70:7092.
11. Nelson, D. R., Marousis, C. G., Davis, G. L. et al. 1997. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. J. Immunol. 158:1473.
12. Adams, S., O'Neill, D. W. and Bhardwaj, N. 2005. Recent advances in dendritic cell biology. J. Clin. Immunol. 25:177.
13. Kanto, T., Hayashi, N., Takehara, T. et al. 1999. Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J. Immunol. 162:5584.
14. Auffermann-Gretzinger, S., Keeffe, E. B. and Levy, S. 2001. Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection. Blood 97:3171.
15. Bain, C., Fatmi, A., Zoulim, F., Zarski, J. P., Trepo, C. and Inchauspe, G. 2001. Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology 120:512.
16. Pachiadakis, I., Pollara, G., Chain, B. M. and Naoumov, N. V. 2005. Is hepatitis C virus infection of dendritic cells a mechanism facilitating viral persistence? Lancet Infect. Dis. 5:296.
17. Lanford, R. E., Chavez, D., Chisari, F. V. and Sureau, C. 1995. Lack of detection of negative-strand hepatitis C virus RNA in peripheral blood mononuclear cells and other extrahepatic tissues by the highly strand-specific rTth reverse transcriptase PCR. J. Virol. 69:8079.
18. Longman, R. S., Talal, A. H., Jacobson, I. M., Alberta, M. L. and Rice, C. M. 2004. Presence of functional dendritic cells in patients chronically infected with hepatitis C virus. Blood 103:1026.
19. Piccioli, D., Tavarini, S., Nuti, S. et al. 2005. Comparable functions of plasmacytoid and monocyte-derived dendritic cells in chronic hepatitis C patients and healthy donors. J. Hepatol. 42:61.
20. Yakushijin, T., Kanto, T., Inoue, M. et al. 2006. Reduced expression and functional impairment of Toll-like receptor 2 on dendritic cells in chronic hepatitis C virus infection. Hepatol. Res. 34:156.
21. Kanto, T., Inoue, M., Miyatake, H. et al. 2004. Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection. J. Infect. Dis. 190:1919.
22. Anthony, D. D., Yonkers, N. L., Post, A. B. et al. 2004. Selective impairments in dendritic cell-associated function distinguish hepatitis C virus and HIV infection. J. Immunol. 172:4907.
23. Longman, R. S., Talal, A. H., Jacobson, I. M., Rice, C. M. and Albert, M. L. 2005. Normal functional capacity in circulating myeloid and plasmacytoid dendritic cells in patients with chronic hepatitis C. J. Infect. Dis. 192:497.
24. Larsson, M., Babcock, E., Grakoui, A. et al. 2004. Lack of phenotypic and functional impairment in dendritic cells from chimpanzees chronically infected with hepatitis C virus. J. Virol. 78:6151.
25. Rollier, C., Drexhage, J. A., Verstrepen, B. E. et al. 2003. Chronic hepatitis C virus infection established and maintained in chimpanzees independent of dendritic cell impairment. Hepatology 38:851.
26. Lau, A. H. and Thomson, A. W. 2003. Dendritic cells and immune regulation in the liver. Gut. 52:307.
27. Koev, G. and Kati, W. 2008. The emerging field of HCV drug resistance. Expert Opin. Investig. Drugs 3:303.
28. Gremion, C. and Cerny, A. 2005. Hepatitis C virus and the immune system: a concise review. Rev. Med. Virol. 15:235.
29. Wedemeyer, H., He, X. S., Nascimbeni, M. et al. 2002. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J. Immunol. 169:3447.
30. Agrawal, B. 2006. Hepatitis C virus and dendritic cells. Curr. Immunol. Rev. 2:305.
31. Tsubouchi, E., Akbar, S. M. F. and Horhke, N. 2004. Distinct susceptibility of dendritic cell subsets to hepatitis C virus infection: a plausible mechanism of dendritic cell dysfunction. J. Gastroenterol. 39:811.
32. Dolganiue, A., Kodys, K., Kopasz, A. et al. 2003. Hepatitis C virus core and nonstructural protein 3 proteins induce proinflammatory cytokines and inhibit dendritic cell differentiation. J. Immunol. 170:5615.
33. Saito, K., Ait-Goughoulte, M., Truscott, S. M. et al. 2008. Hepatitis C virus inhibits cell surface expression of HLA-DR, prevents dendritic cell maturation, and induces interleukin-10 production. J. Virol. 82:3320.
34. Gimmi, C. D., Freeman, G. J., Gribben, J. G., Gray, G. and Nadler, L. M. 1993. Human T cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proc. Natl Acad. Sci. USA 90:6586.
35. Zhou, T., Chen, Y., Hao, L. and Zhang, Y. 2006. DC-SIGN and immunoregulation. Cell. Mol. Immunol. 3:279.
36. Schneider-Schaulies, S. and Meulen, V. 2002. Modulation of immune functions by measles virus. Springer Semin. Immunopathol. 24:127.
37. Pavio, N. and Lai, M. M. 2003. The hepatitis C virus persistence: how to evade the immune system? J. Biosci. 28:287.
38. Li, W., Li, J., Tyrrell, D. L. and Agrawal, B. 2006. Expression of hepatitis C virus-derived core or NS3 antigens in human dendritic cells leads to induction of pro-inflammatory cytokines and normal T-cell stimulation capabilities. J. Gen. Virol. 87:61.
39. Li, W., Krishnadas, D. K., Kumar, R., Tyrrell, D. L. and Agrawal, B. 2008. Priming and stimulation of hepatitis C virus-specific CD4+ and CD8+ T cells against HCV antigens NS4, NS5a or NS5b from HCV-naive individuals: implications for prophylactic vaccine. Int. Immunol. 20:89.
40. Dockrell, D. H., Badley, A. D., Villacian, J. S. et al. 1998. The expression of Fas ligand by macrophages and its upregulation by human immunodeficiency virus infection. J. Clin. Invest. 101:2394.
41. Suss, G. and Shortman, K. 1996. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. J. Exp. Med. 183:1789.
42. Min, W. P., Gorczynski, R., Huang, X. Y. et al. 2000. Dendritic cells genetically engineered to express Fas Ligand induced donor- specific hyporesponsiveness and prolong allograft survival. J. Immunol. 164:161.
43. Lundqvist, A., Nagata, T., Kiessling, R. and Pisa, P. 2002. Mature dendritic cells are protected from Fas/CD95-mediated apoptosis by upregulation of Bcl-XL. Cancer Immunol. Immunother. 51:129.
44. Bjorck, P., Banchereau, J. and Flores-Romo, L. 1997. CD40 ligation counteracts Fas-induced apoptosis of human dendritic cells. Int. Immunol. 9:365.
45. Rescigno, B. M., Piguet, V., Valzasina, B. et al. 2000. Fas engagement induces the maturation of dendritic cells (DCs), the release of interleukin (IL)-1β, IL-12 during DC-T cell cognate interaction: a new role for Fas Ligand in inflammatory responses. J. Exp. Med. 192:1661.
46. Tschopp, J. M., Irmler, M. and Thome, M. 1998. Inhibition of Fas death signals by FLIPs. Curr. Opin. Immunol. 10:552.
47. Siavoshian, S., Abraham, J. D., Thumann, C., Kieny, M. P. and Schuster, C. 2005. Hepatits C virus core, NS3, NS5A, NS5B proteins induce apoptosis in mature dendritic cells. J. Med. Virol. 75:402.
48. Perrella, A., Atripaldi, L., Bellopede, P. et al. 2006. Flow cytometry assay of myeloid dendritic cells (mDCs) in peripheral blood during acute hepatitis C: possible pathogenetic mechanisms. World J. Gastroenterol. 12:1105.
49. Kanto, T., Inoue, M., Miyazaki, M. et al. 2006. Impaired function of dendritic cells circulating in patients infected with hepatitis C virus who have persistently normal alanine aminotransferase levels. Intervirology 49:58.
50. Schvoerer, E., Thumann, C., Spohrer, S. et al. 2006. Early decrease in circulating dendritic cells number after liver transplantation could favor hepatitis C virus recurrence. J. Med. Virol. 78:1070.
51. Vajidy, M., Selby, M., Medina-Selby, A. et al. 2006. Hepatitis C virus polyprotein vaccine formulations capable of inducing broad antibody and cellular immune responses. J. Gen. Virol. 87:2253.
52. Janeway, C. A. Jr. and Medzhitov, R. 2002. Innate immune recognition. Annu. Rev. Immunol. 20:197.
53. Robinson, M. J., Sancho, D., Slack, E. C., LeibundGut-Landmann, S. and Reise Sousa, C. 2006. Myeloid C-type lectins in innate immunity. Nat. Immunol. 7:1258.
54. Kanneganti, T. D., Lamkanfi, M. and Nunez, G. 2007. Intracellular NOD-like receptors in host defense and disease. Immunity. 27:549.
55. Meylan, E. and Tschopp, J. 2006. Toll-like receptors and RNA helicases: two parallel ways to trigger antiviral responses. Mol. Cell. 22:561.
56. Takeda, K., Kaisho, T. and Akira, S. 2003. Toll-like receptors. Annu. Rev. Immunol. 21:335.
57. Kawai, T. and Akira, S. 2007. TLR signaling. Semin. Immunol. 19:24.
58. Dolganiuc, A., Garcia, C., Kodys, K. and Szabo, G. 2006. Distinct toll-like receptor expression in monocytes and T cells in chronic infection. World J. Gastroenterol. 28:1198.
59. Sato, K., Ishikawa, T., Okumura, A. et al. 2007. Expression of Toll-like receptors in chronic hepatitis C virus infection. J. Gastroenterol. Hepatol. 22:1627.
60. Granucci, F., Zanoni, I. and Ricciardi-Castagnoli, P. 2008. Central role of dendritic cells in the regulation and deregulation of immune responses. Cell. Mol. Life Sci. 65:1683.
61. Kaisho, T. and Akira, S. 2006. Toll-like receptor function and signaling. J. Allergy Clin. Imunol. 117:979. Quiz 988.
62. Kato, H., Sato, S., Yoneyama, M. et al. 2005. Cell type-specific involvement of RIG-I in antiviral response. Immunity 23:19.
63. Meylan, E., Curran, J., Hofmann, K. et al. 2005. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437:1167.